Login / Signup

Dose-Dependent Risk Reduction for Myocardial Infarction with Eicosapentaenoic Acid: a Meta-analysis and Meta-regression Including the STRENGTH Trial.

Philip SarajlicGonzalo ArtiachSusanna C LarssonMagnus Bäck
Published in: Cardiovascular drugs and therapy (2021)
Keyphrases
  • heart failure
  • study protocol
  • phase iii
  • clinical trial
  • left ventricular
  • phase ii
  • open label